主要文件

查看所有文档

428949

4-甲基-3-硝基苯甲酰氯

Name: 4-甲基-3-硝基苯甲酰氯
Brand: ALDRICH

99%

别名:

3-硝基-4-甲基苯甲酰氯

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:

CH₃C₆H₃(NO₂)COCl

化学文摘社编号:

10397-30-5

分子量:

199.59

NACRES:

NA.22

PubChem Substance ID:

24866825

UNSPSC Code:

12352100

EC Number:

233-858-1

MDL number:

MFCD00035747

Assay:

99%

Form:

liquid

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

assay

99%

form

liquid

refractive index

n20/D 1.581 (lit.)

bp

185 °C/36 mmHg (lit.)

mp

20-21 °C (lit.)

density

1.37 g/mL at 25 °C (lit.)

functional group

acyl chloride, nitro

SMILES string

Cc1ccc(cc1[N+]([O-])=O)C(Cl)=O

InChI

1S/C8H6ClNO3/c1-5-2-3-6(8(9)11)4-7(5)10(12)13/h2-4H,1H3

InChI key

DXMHBBURYDVYAI-UHFFFAOYSA-N

说明

General description

4-Methyl-3-nitrobenzoyl chloride is a benzoyl chloride derivative. It has been reported to be synthesized from 4-methyl-3-nitrobenzoic acid.

Application

4-Methyl-3-nitrobenzoyl chloride was used in the synthesis of 4-amino-1,5-naphthalenedisulphonate acid monosodium salt, an intermediate employed in the synthesis of modified suramin molecule.
It may be used in the synthesis of the following:

benzophenone derivative
substituted 3-amino-4-methyl-N-phenylbenzamide
retroamide
4-methyl-3-nitro-N-phenylbenzamide

pictograms

GHS05

signalword

Danger

hcodes

H314

pcodes

P280 - P303 + P361 + P353 - P304 + P340 + P310 - P305 + P351 + P338 - P363 - P405

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B

存储类别

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Design, synthesis and biological evaluation of novel acrylamide analogues as inhibitors of BCR-ABL kinase.

Shuxin Li et al.

Bioorganic & medicinal chemistry letters, 22(16), 5279-5282 (2012-07-14)

A series of acrylamide analogues were designed and synthesized from Imatinib and Nilotinib as novel BCR-ABL inhibitors by application of the principle of nonclassical electronic isostere. All new compounds were evaluated for their inhibitory effects on the activity of BCR-ABL

N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR.

Holly L Deak et al.

Bioorganic & medicinal chemistry letters, 18(3), 1172-1176 (2007-12-18)

N-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides are a novel class of selective Lck inhibitors. This series of compounds derives its selectivity from a hydrogen bond with the gatekeeper Thr316 of the enzyme. X-ray co-crystal structural data, structure-activity relationships, and the synthesis of these inhibitors are

New low-density lipoprotein receptor upregulators acting via a novel mechanism.

M J Ashton et al.

Journal of medicinal chemistry, 39(17), 3343-3356 (1996-08-16)

The synthesis and biological activity of a new series of benzamides and related compounds that upregulate the expression of the low-density lipoprotein (LDL) receptor in human hepatocytes (HepG2 cells) by a novel mechanism are described. The lead compound, N-[5-[(3-cyclohexylpropionyl)amino]-2-methylphenyl]-4-hydroxybe nzamide

查看所有相关文献

全球贸易项目编号

货号	GTIN
428949-10ML	04061832105161
428949-50ML	04061837499647